Primecap Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-74,950
| Closed | -$1.62M | – | 338 |
|
|
2023
Q4 | $1.62M | Sell |
74,950
-14,900
| -17% | -$323K | ﹤0.01% | 316 |
|
|
2023
Q3 | $1.85M | Buy |
89,850
+26,250
| +41% | +$540K | ﹤0.01% | 305 |
|
|
2023
Q2 | $2.99M | Sell |
63,600
-2,800
| -4% | -$132K | ﹤0.01% | 295 |
|
|
2023
Q1 | $2.79M | Buy |
66,400
+1,800
| +3% | +$75.5K | ﹤0.01% | 295 |
|
|
2022
Q4 | $2.46M | Sell |
64,600
-13,200
| -17% | -$503K | ﹤0.01% | 293 |
|
|
2022
Q3 | $3.05M | Hold |
77,800
| – | – | ﹤0.01% | 292 |
|
|
2022
Q2 | $2.51M | Buy |
77,800
+9,000
| +13% | +$291K | ﹤0.01% | 300 |
|
|
2022
Q1 | $2.28M | Buy |
68,800
+4,700
| +7% | +$156K | ﹤0.01% | 307 |
|
|
2021
Q4 | $2.73M | Buy |
+64,100
| New | +$2.73M | ﹤0.01% | 309 |
|